PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 268 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $456 | -23.4% | 14,868 | 0.0% | 0.01% | -16.7% |
| Q2 2023 | $595 | +3.7% | 14,868 | +5.7% | 0.01% | 0.0% |
| Q1 2023 | $574 | -52.9% | 14,063 | -55.5% | 0.01% | -53.8% |
| Q4 2022 | $1,219 | -99.9% | 31,574 | +3.7% | 0.01% | -31.6% |
| Q3 2022 | $1,619,000 | -23.2% | 30,439 | +10.2% | 0.02% | -9.5% |
| Q1 2022 | $2,107,000 | +189.4% | 27,616 | +128.2% | 0.02% | +250.0% |
| Q4 2021 | $728,000 | +7.4% | 12,100 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $678,000 | -7.6% | 12,100 | 0.0% | 0.01% | -14.3% |
| Q2 2021 | $734,000 | -13.4% | 12,100 | 0.0% | 0.01% | -12.5% |
| Q1 2021 | $848,000 | +17.1% | 12,100 | 0.0% | 0.01% | +14.3% |
| Q4 2020 | $724,000 | -0.4% | 12,100 | 0.0% | 0.01% | -12.5% |
| Q3 2020 | $727,000 | +14.5% | 12,100 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $635,000 | +56.4% | 12,100 | 0.0% | 0.01% | +33.3% |
| Q1 2020 | $406,000 | -29.4% | 12,100 | -4.7% | 0.01% | 0.0% |
| Q4 2019 | $575,000 | – | 12,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |